drugset / Trial / NCT00484536
Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of the study is to evaluate the effect, safety and tolerability of CDP323 in patients with relapsing forms of multiple sclerosis
Timeline
- Start
- 2007-05
- Primary completion
- 2009-11
- Completion
- 2010-07
Outcome
Outcome not reported
Stopped: “The study was discontinued due to unfavorable interim analysis”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | UCB-1184197 | Small molecule | 500 mg | — |
| Subject | UCB-1184197 | Small molecule | 1000 mg | — |